{"product_id":"citrosil-0-175-100-ml-spray-soluzione-cutanea","title":"Citrosil 0.175% 100 ml spray skin solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDisinfection and cleaning of skin, including damaged skin (wounds, abrasions, abrasions, burns).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml of skin solution contains: ACTIVE INGREDIENT: benzalkonium chloride 0.175 g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLemon essence, thyme essence, ethyl alcohol, polysorbate 20, tetrasodium edetate, quinoline yellow (E 104), patent blue (E 131), hydrochloric acid, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Do not administer to children under 1 year of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eMethod of administration\u003c\/u\u003e \u003cu\u003eSolution\u003c\/u\u003e Ready-to-use solution. It must be used pure. Intact skin: rub the affected area with gauze soaked in the solution. Superficial lesions: apply the product with a sterile gauze compress. Apply two – three times a day. \u003cu\u003eSprays\u003c\/u\u003e Spray on the area to be treated two – three times a day. DO NOT EXCEED THE RECOMMENDED DOSES.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original package to protect the medicine from light and heat. For storage conditions after first opening see paragraph 6.3.6.5\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product is for external use only. Avoid contact with eyes, brain, meninges and middle ear. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult your doctor. Do not use for disinfection of mucous membranes. The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena; in this case stop treatment and consult your doctor. Accidental ingestion or inhalation of some disinfectants can have serious, sometimes fatal, consequences. Avoid exposure to ultraviolet rays (sun or artificial sources) after applying the product.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid the simultaneous use of other antiseptics and detergents. \u003cu\u003ePediatric population\u003c\/u\u003e Interaction studies have only been carried out in adults.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following adverse reactions have been identified since the authorization for use of benzalkonium chloride. Since these reactions arise from spontaneous reports, it is not always possible to define their frequency. It is possible, in some cases, to cause intolerance (burning or irritation), however without consequences, which does not require modification of treatment. \u003cu\u003ePediatric population\u003c\/u\u003e The same frequency, type and severity of side effects are expected in the pediatric population as in the adult population. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUnder normal conditions of use, no damage from overdose has been reported. Accidental ingestion may cause nausea and vomiting. Symptoms of intoxication following the ingestion of significant quantities of quaternary ammonium compounds include dyspnoea, cyanosis, asphyxia resulting from paralysis of the respiratory muscles, CNS depression, hypotension and coma. In humans the lethal dose is approximately 1–3g. Treatment of poisoning is symptomatic: administer soothing medications if necessary. Avoid emesis and gastric lavage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e The product should only be used in cases of actual necessity. During the breastfeeding period, avoid applying the product to the breast to avoid ingestion of the product by the infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCitrosil does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Manetti \u0026 Roberts","offers":[{"title":"Default Title","offer_id":51730213699911,"sku":"032781116","price":6.42,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/l-manetti-h-roberts-c-spa-citrosil-0-175-100-ml-spray-soluzione-cutanea-farmacia-dottor-tili-1213790995.jpg?v=1767156168","url":"https:\/\/www.dottortili.com\/en-eu\/products\/citrosil-0-175-100-ml-spray-skin-solution","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}